A study of major depressive disorder and quality of life in patients with oral cancer

Authors

  • Archana Surajprasad Kantak Department of Psychiatry, Government Medical College, Bhavnagar, Gujarat, India
  • Ashokkumar Ukabhai Vala Department of Psychiatry, Government Medical College, Bhavnagar, Gujarat, India
  • Bharat Navinchandra Panchal Department of Psychiatry, Government Medical College, Bhavnagar, Gujarat, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20162050

Keywords:

Oral cancer, Depression, Quality of life

Abstract

Background: Head and neck cancer (HNC) is one of the 10 most frequently occurring cancers worldwide, with estimates of over 500,000 new cases annually and one of the 10 leading causes of cancer mortality. Head and neck cancer patients experience among the highest rates of major depressive disorder of all oncology patients. The aim of this study was to find out the frequency of major depressive disorder (MDD) and its association with quality of life in patients with oral cancer.

Methods: This is a single-center, cross sectional, observational, questionnaire based study. Seventy consecutive patients, who attended Oncology Outpatient Department of Tertiary care Hospital with diagnosis of Oral cancer were included. Diagnosis of Major Depressive Disorder was done by clinically administered interview as per DSM V. The patients were further assessed for demographic details, HADS-A(Hospital Anxiety and Depression scale for Anxiety),HADS-D (Hospital Anxiety and Depression scale for Depression), FACT H&N QOL (Functional Assessment of Cancer Therapy Head and Neck Quality of Life Scale).Data were analyzed by GraphPad  InStat trial version. Proportions were compared by using Chi-square test, HADS-A, HADS-D and FACT H and N QOL scores were compared by Mann-Whitney U test. P value <0.05 was considered to be statistically significant.

Results: Frequency of MDD in Oral Cancer patients is 40%.The Patients having Major Depressive Disorder showed higher HADS-A (p<0.0001), HADS-D (p<0.0001)scores and poorer quality of life in all domains of FACT H and N QOL.

Conclusions: The Patients with Oral Cancer have higher rates of depression and poor quality of life. 

References

Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. Institute Monographs. 2004:32.

Chen YJ, Chang JT, Liao CT, Wang HM, Yen TC, Chiu CC, et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci. 2008;99:1507-14.

Hammerlid E, Mercke C, Sullivan M, Westin T. A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapy. Oral Oncol. 1997;33:189-96.

Hammerlid E, Ahlner-Elmqvist M, Bjordal K. A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer. 1999;80:766-74.

Hammerlid E, Silander E, Hornestam L, Sullivan M. Health-related quality of life three years after diagnosis of head and neck cancer - a longitudinal study. Head Neck. 2001;23:113-25.

Sehlen S, Lenk M, Herschbach P, Aydemir U, Dellian M, Schymura B, Hollenhorst H, Duhmke E. Depressive symptoms during and after radiotherapy for head and neck cancer. Head Neck. 2003;25:1004-18.

McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer. Arch Gen Psychiatry. 1995;52:89-97.

Frampton M. Psychologic distress in patients with head and neck cancer: review. Br J Oral Maxillofacial Surg. 2001;39:67-70.

Morton RP, Davies ADM, Baker J, Baker GA, Stell PM. Quality of life in treated head and neck cancer patients: a preliminary report. Clin Otolaryngology. 1984;15:61-9.

Baile WF, Gilbertini M, Scott L, Endicott J. Depression and tumor stage in cancer of the head and neck. Psycho-Oncology. 1992;1:15-24.

Lydiatt WM, Denman D, McNeilly DP, Puumula SE, Burke WJ. A randomized, placebo-controlled trial of citalopram for the prevention of major depression.

Sehlen S, Lenk M, Herschbach P, Aydemir U, Dellian M, Schymura B, Hollenhorst H, Duhmke E. Depressive symptoms during and after radiotherapy for head and neck cancer. Head Neck. 2003;25:1004-18.

Mehanna H, Paleri V, West CM, Nutting C. Head and neck cancer-part 1: epidemiology, presentation, and prevention. BMJ. 2010;341:c4684.

Ganz PA. Quality of life and the patient with cancer: individual and policy implications. Cancer. 1994;74:1445-52.

de Boer MF, McCormick LK, Pruyn JFA, Ryckman RM, van den Borne BW.Physical and psychosocial correlates of head and neck cancer: a review of the literature. Otolaryngol Head Neck Surg. 1999;120:427-36.

List MA, Stracks J. Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck. Curr Opin Oncol. 2000;12:215-20.

Zigmond AA, Snaith RP. The Hospital Depression and Anxiety Scale. Acta Psychaitr Scand. 1983;67(6):361-70.

Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale;development and validation of general measures. J Clin Oncol.1993;11(3):570-9.

Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 1995;24(10):450-3.

WY Chiou, MS Lee, HC Ho, SK Hung, HY Lin, YC Su, CC Lee. Prognosticators and the relationship of depression and quality of life in head and neck cancer. Indian J Cancer. 2013;50:1.

Downloads

Published

2016-12-28

How to Cite

Kantak, A. S., Vala, A. U., & Panchal, B. N. (2016). A study of major depressive disorder and quality of life in patients with oral cancer. International Journal Of Community Medicine And Public Health, 3(7), 1829–1834. https://doi.org/10.18203/2394-6040.ijcmph20162050

Issue

Section

Original Research Articles